For the first time ever, I’ve changed my taskbar at work to be two ‘lines’ tall. Because I was actually out of space with the standard height.
Argh. *headdesk*
–TSK
Items that apply to ‘interesting’ subjects in my Real Life.
For the first time ever, I’ve changed my taskbar at work to be two ‘lines’ tall. Because I was actually out of space with the standard height.
Argh. *headdesk*
–TSK
Good morning!
Sitting in theater waiting for midnight showing to start.
Nice bonus – paid for normal one and was sent to the 3D one. Hope its worth it…
I mentioned this in CyanChat over the weekend, so figured it would be a good idea to repeat here.
I’m in the process of moving again (not sure if a ‘finally’ would fit as well ;). Not exactly a light decision, but it does feel a bit hurried (and, in some respects, it is). Still, Craig found the place, its much closer to work (though farther away from family) and is over twice the floor space for about $700 less per month.
So far the only concerns I have are electrical (the place in question is old enough to only have two-prong plugs) and parking (the street has cleaning restrictions on Mon morning); Still working those out.
The first set of boxes have already started to stage themselves at the new place, and once again I’m being hit with the ‘fun’ of packing (and realizing how entrenched you get after ten years).
More on this later, as I deal with it. :)
–TSK
Note to self: Don’t pay off the car loan on a full moon, or near it. :p
(Don’t worry, it – and I – am OK, just annoyed at what happened today.)
–TSK
PS – And yes, the 2010 weblog posts are a *bit* thin nowadays. Thinking about how to fix that; Maybe focus more on EvE-centered activities for awhile…
I’ve stumbled onto an short news item regarding the acne medicine Accutane. Quote is from Myway’s news section, as an AP newswire (http://apnews.myway.com/article/20100217/D9DTLS5O3.html).
ATLANTIC CITY, N.J. (AP) – A New Jersey jury has hit the pharmaceutical company that makes Accutane with a $25.16 million judgment in a lawsuit filed by an Alabama man who blamed the drug for his inflammatory bowel disorder.
Thirty-eight-year-old Andrew McCarrell of Moody, Ala., took the acne drug in his 20s. He says Hoffmann-La Roche Inc. failed to adequately warn of its side effects. McCarrell eventually had his colon removed.
The compensatory damages award came Tuesday in a retrial. An appeals court overturned a $2.6 million judgment he won in May 2007.
Hoffmann-La Roche stopped selling the drug in June 2009. It cited generic competition and the cost of defending against lawsuits, which have sought to blame the drug for suicidal behavior and birth defects.
The Nutley, N.J.-based company says it will appeal.
What I find most interesting is that they finally stopped selling it, and that it took so long to get to this point. I’ve taken Accutane three times over the years, with varying degrees of success. But like some patients, it affected me mentally and I had refused taking it since then. It also only took about 5 or so years after taking it for some of my acne to come back to previous levels, though not as much on the face as it used to in the past.
I’m actually having better success these days with colloidal silver (ingested and topical) as well as tea tree oil (topical), though both are painfully slow. At least they’re natural, and the tea tree oil does have pleasing scent to it. Still need to be careful with them though.
–TSK
Bad Behavior has blocked 193 access attempts in the last 7 days.